Aspire Growth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$695K Buy
2,353
+5
+0.2% +$1.49K 0.48% 49
2025
Q4
$641K Sell
2,348
-126
-5% -$34.2K 0.45% 49
2025
Q3
$669K Buy
2,474
+11
+0.4% +$2.99K 0.49% 46
2025
Q2
$679K Sell
2,463
-512
-17% -$139K 0.56% 43
2025
Q1
$847K Buy
2,975
+616
+26% +$152K 0.75% 34
2024
Q4
$548K Buy
+2,359
New +$542K 0.54% 48

Other funds holding CME

Aspire Growth Partners's CME Position: Q1 2026 in Review

Aspire Growth Partners increased its CME Group (CME) stake by 0.21% in Q1 2026, buying an estimated $1.49K and bringing the position to 2,353 shares worth $695K. The position accounts for 0.48% of the portfolio, ranked #49.

Aspire Growth Partners first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $847K in Q1 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Aspire Growth Partners held 2,353 shares of CME Group worth $695K as of Q1 2026.
  • Aspire Growth Partners bought 5 CME Group shares in Q1 2026, an estimated $1.49K.
  • CME Group made up 0.48% of Aspire Growth Partners's portfolio in Q1 2026, its #49 holding.
  • Aspire Growth Partners first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Aspire Growth Partners's CME Group position peaked at $847K in Q1 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.